传染性法氏囊病病毒毒力变异的趋势

鸡传染性法氏囊病 (ＩＢＤ)是鸡的一种急性高度接触性传染病 ,其病原为鸡传染性法氏囊病病毒 (ＩＢＤＶ)。ＩＢＤＶ主要侵害鸡的体液免疫中枢器官———法氏囊 ,导致免疫抑制 ,从而降低机体对其他传染病的免疫反应。鸡群早期感染ＩＢＤ以后 ,对其他病毒病和细菌病的易感性增高 ,同时影响新城疫、马立克氏病等的免疫效果。ＩＢＤＶ的某些毒株能使 3周龄以上的鸡发病 ,其死亡率可高达 1 0 0 % ,而且ＩＢＤＶ变异株和超强毒株的出现 ,也使ＩＢＤ本身免疫经常失败。因此本病已成为世界上最严重的传染病之一。ＩＢＤＶ无囊膜 ,属双股双链ＲＮＡ病…     

传染性法氏囊病及其病原分子生物学研究进展

传染性法氏囊病(Infectious bursal disease,IBD)是由传染性法氏囊病病毒(Infectious bursal disease virus,IBDV)引起的一种急性、高度接触性传染病.20世纪80年代中期以后,由于抗原变异和超强毒株在免疫鸡群的出现,使IBD的防控面临新的困难.文章简要概述近几年来,IBD在病原及分子生物学特性、抗原性、致病性、毒力与抗原的变异、疾病诊断和防制策略等方面的研究进展.     

鸡传染性法氏囊病新型疫苗的研究进展

鸡传染性法氏囊病(IBD)是由鸡传染性法氏囊病病毒(IBDV)引起的雏鸡的一种高度接触性传染病,自1962年报道以来,世界上主要养禽国家和地区均有流行,给养禽业带来严重经济损失。目前,IBD防控的主要方法是采用疫苗接种,使易感雏鸡获得主动或被动免疫保护,因此疫苗的质量对临床上IBD的防控起着至关重要的作用。虽然各国均有较好的商品化疫苗,但随着IBDV毒株的不断变异,商品化疫苗的抗原性与流行毒株不能完全匹配,临床上免疫失败时有发生,因此迫切需要研发与临床流行毒株相匹配的新型疫苗用于IBD的防控。对近期IBD的基因缺失苗、亚单位疫苗、DNA疫苗以及活载体疫苗等新型疫苗的研究进展进行概述,以此为IBD新型疫苗的研究提供参考。     

传染性法氏囊病病毒变异的分子生物学研究进展

传染性法氏囊病（infectious bursal disease，IBD)是由传染性法氏囊病病毒(IBDV)引起的鸡和火鸡的一种急性高度接触性传染病。该病主要侵害3～6周龄雏鸡与青年鸡，以损害法氏囊中的淋巴细胞为特征；临床上出现增重减少、死亡、机体严重脱水和骨骼肌出血…。除直接引起鸡死亡与生产性能     

传染性法氏囊病研究进展

传染性法氏囊病是由传染性法氏囊病病毒引起的一种严重危害养鸡业的免疫抑制性传染病。该病在临床上以侵害鸡的中枢免疫器官法氏囊为主要特征。对传染性法氏囊病病毒的分子特征、抗原和毒力变异以及防控技术的研究进展进行综述,以期为该病的防控奠定基础。     

传染性法氏囊病研究进展

传染性法氏囊病是由传染性法氏囊病病毒引起的一种严重危害养鸡业的免疫抑制性传染病。该病在临床上以侵害鸡的中枢免疫器官法氏囊为主要特征。对传染性法氏囊病病毒的分子特征、抗原和毒力变异以及防控技术的研究进展进行综述,以期为该病的防控奠定基础。     

传染性法氏囊病病毒变异的分子基础

鸡传染性法氏囊病病毒(IBDV)是传染性法氏囊病(IBD)的病原体。由于急性感染的高死亡率和亚临床感染严重的免疫抑制,IBDV对养禽业经济上有重大的影响[11,14]。IBDV共有两个血清型,即1型和2型,血清1型对鸡有致病性,血清2型分离自火鸡,对鸡无致病性。J.Rosenberger(1985)首次从美国特拉华半岛肉鸡群分离到4株IBDV变异株,1987年,荷兰、比利时爆发了与美国株不同的超强病毒(vvIBDV)。而后,英国、法国、西班牙、德国等欧洲国家相继分离到超强毒株。李树根(1991)等首次在国内分离到血清亚型株,李德山(1991)首次报道了中国超强毒株,朱爱国…     

传染性法氏囊病病毒广西分离株血清亚型的确定

应用兔制备的抗传染性法氏囊病病毒(IBDV)高免血清,在鸡胚成纤维细胞(CEF)上对从广西发病鸡群分离的4个IBDV代表性流行毒株和2个常用疫苗株进行交叉中和试验。结果表明6个毒株被分为2个血清亚型;根据试验所得的R值,应用聚类分析法分析了各亚型毒株之间的亲缘关系,结果显示目前在广西流行的IBDV野毒株之间以及其与疫苗株间的抗原性存在一定的差异。研究结果对及时掌握广西IBDV流行毒株的抗原变异并为研制更有效的适合本地使用的IBD疫苗提供了科学依据。     

Immunoreactivity and morphological changes of bursal follicles in chickens infected with vaccine or wild-type strains of the infectious bursal disease virus

Infectious bursal disease (IBD) is characterized by immunosuppression due to the depletion of lymphocytes in the atrophied bursa of Fabricius (BF). We have sometimes encountered contradictory findings: chickens infected with the vaccine IBD virus (IBDV) strain have sometimes exhibited a highly atrophied BF, but not immunosuppression. In this study, chickens administered vaccine or wild-type strains of IBDV were later vaccinated with the B1 strain of the Newcastle disease virus (NDV). Bursal changes were examined histologically with a focus on the bursal follicle. The immunoreactivity to NDV was also evaluated with the hemagglutination inhibition test. In gross examination, we observed a few chickens with a severely atrophied BF in vaccine strain-administered groups (vaccine groups), and the level of severity was the same as that in the wild-type strain-administered group (wild-type group). However, these chickens retained humoral antibody responses to NDV and were revealed to possess a higher number of bursal follicles than those of the wild-type group. These results indicated that macroscopic evaluation dose not accurately reflect the immunoreactivity and degree of bursal damage in IBDV-administered chickens. We also found non-immunosuppressed chickens in the wild-type group. These non-immunosuppressed chickens retained a significantly higher number of normal follicles and total follicles according to our statistical analysis. Furthermore, a high correlation coefficient between the NDV-HI titer and the number of normal follicles was found in the wild-type group. These results implied that the retained number of normal follicles is important for the immunoreactivity of chickens infected with IBDV.     

反向遗传技术在传染性法氏囊病病毒研究中的应用

传染性法氏囊病是鸡的最严重疾病之一,其病原是鸡传染性法氏囊病病毒(IBDV),IBDV基因组为两片段双链RNA,变异株和超强毒株的出现,给传统的疫苗免疫带来了新的挑战,因此,加强对IBDV的基础研究是控制该病的关键.RNA的结构不稳定成为阻碍RNA病毒研究的主要障碍,近年来兴起的反向遗传技术将RNA病毒的基因组转化为cDNA,从而使RNA病毒的基因操作成为可能,也使RNA病毒的研究获得了快速的发展.文章就传染性法氏囊病病毒反向遗传操作研究的意义、方法、概况及相关分子生物学进行了全面综述.     

鸡传染性法氏囊病病毒X-28弱毒株的致病性试验

在Vero细胞上适应且连续传17代的传染性法氏囊病病毒X毒株IBDVX,再经鸡胚成纤维细胞CEF连续传代后,得到了适应CEF细胞生长且毒力相对稳定的的弱毒株(IBDVX-28)。IBDVX-28~IBDVX-43代毒均能在72h~96h内产生明显的细胞病变效应(CPE),半数细胞感染量(TCID50)在10-8.47/0.1mL~10-9.26/0.1mL之间,半数鸡胚感染量(EID50)在10-4.71/0.2mL~10-5.80/0.2mL之间。致病性试验表明,各代次毒能引起10日龄鸡胚40%~50%的感染或死亡,对30日龄SPF小鸡基本无致病性,所有试验鸡均未见法氏囊明显的眼观病变,囊指数(b/B)平均为0.35±0.040;IBDVX-28代毒在雏鸡体内回归6代,均未见法氏囊明显的眼观病变,囊指数保持稳定。     

不同来源鸡传染性法氏囊病疫苗的免疫效果观察

为了研究商品蛋雏鸡传染性法氏囊病疫苗的免疫程序,对MB株活疫苗、G606株活疫苗和B38株活疫苗3株传染性法氏囊病活疫苗进行了疫苗毒力、免疫效果及对新城疫疫苗免疫影响的观察。结果表明,MB株活疫苗毒力最强,G606株活疫苗次之,B38株活疫苗毒力最弱;突破母源抗体能力强弱依次为MB株活疫苗、G606株活疫苗、B38株活疫苗,其中B38株活疫苗产生的抗体滴度最高,MB株活疫苗次之,G606株活疫苗最低;MB株活疫苗可降低新城疫疫苗产生的血凝抑制抗体滴度,G606株活疫苗和B38株活疫苗对此无影响。     

一株传染性法氏囊病病毒强毒株的分离与鉴定

鸡传染性法氏囊病是由传染性法氏囊病病毒引起的一种急性传染病。本研究从江苏某疑似发生传染性法氏囊病的鸡场采集病料,通过观察临床症状、病理变化、RT-PCR检测、基因测序、SPF鸡胚接种、琼脂扩散试验和雏鸡攻毒等试验,证实了该鸡群发生了传染性法氏囊病,且分离到一株传染性法氏囊病病毒(JSXY株),该病毒有较强的致病力,VP4基因比较分析发现其与变异株亲缘关系最近,序列同源性为95%。本研究为江苏地区传染性法氏囊病的防治提供了有益的参考。     

传染性法氏囊病疫苗免疫雏鸡局部体液的免疫学变化

应用间接ELISA法,检测了传染性法氏囊病疫苗免疫雏鸡4种局部体液(泪液、气管液、胆汁、肠液)免疫球蛋白IgG、IgM、IgA含量的动态变化。结果发现免疫雏鸡局部体液3种免疫球蛋白含量较未免疫对照雏鸡均有不同程度地升高;IBD超强毒株攻击后,对照雏鸡上述指标均明显低于疫苗免疫雏鸡,发生典型IBD,并全部死亡,而疫苗免疫雏鸡免疫保护率达60%,表明疫苗免疫后,可增强雏鸡的局部体液免疫功能。     

Efficacy of a novel in ovo-attenuated live vaccine and recombinant vaccine against a very virulent infectious bursal disease virus in chickens

Infectious bursal disease (IBD) causes severe economic damage to the poultry industry worldwide. To prevent IBD virus (IBDV) infection, live virus vaccines have been widely used in chickens having wide-ranging levels of maternally derived antibodies. But, the risks of infection with other pathogens because of lesions related to atrophy of the bursa of Fabricius in vaccinated chickens are a concern. To resolve the problems, a recombinant turkey herpesvirus (HVT) vaccine expressing IBDV-VP2 protein (rHVT-IBD) has been developed. However, the induction of neutralizing antibodies by rHVT-IBD against a virulent IBDV might be delayed compared with that by the live IBD vaccine, leading to the high risks of IBDV infection for young chickens. To find the best selection of IBDV vaccine for the onset of immunity, we examine the protective efficacy of a novel in ovo-attenuated live IBDV (IBD-CA) vaccine and the rHVT-IBD vaccine in young chickens challenged with a very virulent IBDV (vvIBDV) strain. We show that the protective efficacy of IBD-CA vaccine was higher than that of the rHVT-IBD vaccine in 14-day-old chickens challenged with the vvIBDV strain, leading to the risk of IBDV infection for young chickens when vaccinated with rHVT-IBD. Our results suggest that farmers should select the best vaccines to maximize vaccine efficacy in consideration of the vaccine characteristics, prevalence levels of IBDV in the areas, and initial MDA levels of the chickens since the attenuated live and recombinant vaccines play a role in the different vaccine efficacies.